Similar articles

• Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?

  Vogt L, Kocks MJ, Laverman GD, Navis G. Vogt L, et al. Minerva Med. 2004 Oct;95(5):395-409. Minerva Med. 2004. PMID: 15467515 Review.
• Effects of angiotensin II and of angiotensin converting enzyme inhibition in chronic renal failure.

  Ledingham JG. Ledingham JG. Kidney Int Suppl. 1987 May;20:S112-6. Kidney Int Suppl. 1987. PMID: 3037159 Review. No abstract available.
• Angiotensin II receptor blockade in diabetic nephropathy.

  Andersen S. Andersen S. Dan Med Bull. 2004 Aug;51(3):274-94. Dan Med Bull. 2004. PMID: 16009059 Review. No abstract available.
• Progression of chronic kidney disease: can it be prevented or arrested?

  Jaber BL, Madias NE. Jaber BL, et al. Am J Med. 2005 Dec;118(12):1323-30. doi: 10.1016/j.amjmed.2005.02.032. Am J Med. 2005. PMID: 16378772 Review.
• Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.

  Hirsch S. Hirsch S. Compr Ther. 2009 Summer;35(2):91-5. Compr Ther. 2009. PMID: 19618757 Review.